Laurent Arnaud

Strasbourg, France

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 311 publications

Towards a global collaborative approach to living guideline development in rheumatology.

Towards a global collaborative approach to living guideline development in rheumatology.

Journal: Nature reviews. Rheumatology
Published: August 24, 2026

The lupus damage index revision program: Results from the item generation and reduction phases.

The lupus damage index revision program: Results from the item generation and reduction phases.

Journal: Lupus science & medicine
Published: July 30, 2026

Disease modification in lupus nephritis: towards a pathophysiology-based treatment paradigm.

Disease modification in lupus nephritis: towards a pathophysiology-based treatment paradigm.

Journal: Nature reviews. Nephrology
Published: July 02, 2026

International development of a lupus-specific instrument to assess cognitive symptoms in patients with SLE: Lupus Brain Fog Severity Scale (LBFSS) study.

International development of a lupus-specific instrument to assess cognitive symptoms in patients with SLE: Lupus Brain Fog Severity Scale (LBFSS) study.

Journal: Lupus science & medicine
Published: May 07, 2026

Evolving Economic Burden of Spondyloarthritis (2015-2023): A Nationwide Analysis of Direct and Indirect Costs.

Evolving Economic Burden of Spondyloarthritis (2015-2023): A Nationwide Analysis of Direct and Indirect Costs.

Journal: Joint bone spine
Published: April 30, 2026

Evolution of direct and indirect costs of rheumatoid arthritis and related conditions in France: a 2015-2023 nation-wide population-based study.

Evolution of direct and indirect costs of rheumatoid arthritis and related conditions in France: a 2015-2023 nation-wide population-based study.

Journal: Joint bone spine
Published: April 28, 2026

Development and validation of a relapsing polychondritis disease-specific quality of life instrument (ERN ReCONNET RP-QoL).

Development and validation of a relapsing polychondritis disease-specific quality of life instrument (ERN ReCONNET RP-QoL).

Journal: Rheumatology (Oxford, England)
Published: April 07, 2026

Relapse risk of lupus-related serositis according to immunosuppressive therapy: a national real-world study.

Relapse risk of lupus-related serositis according to immunosuppressive therapy: a national real-world study.

Journal: RMD open
Published: March 09, 2026

ERN ReCONNET-SLICC-SLEuro consensus on the therapeutic management of rare systemic lupus erythematosus manifestations (part 2).

ERN ReCONNET-SLICC-SLEuro consensus on the therapeutic management of rare systemic lupus erythematosus manifestations (part 2).

Journal: The Lancet. Rheumatology
Published: February 17, 2026

The Lupus Damage Index Revision Program: Results From the Item Generation and Reduction Phases.

The Lupus Damage Index Revision Program: Results From the Item Generation and Reduction Phases.

Journal: Arthritis care & research
Published: November 14, 2025

Methodology for eliciting consensus on high-level concepts in rare connective tissue and musculoskeletal diseases (ReCONNET-ELICIT).

Methodology for eliciting consensus on high-level concepts in rare connective tissue and musculoskeletal diseases (ReCONNET-ELICIT).

Journal: Orphanet journal of rare diseases
Published: November 07, 2025

A Global Survey of Quinacrine Use in Systemic and Cutaneous Lupus Erythematosus.

A Global Survey of Quinacrine Use in Systemic and Cutaneous Lupus Erythematosus.

Journal: The Journal of rheumatology
Published: November 04, 2025
Showing 1-12 of 311

Last Updated: 09/26/2026